Chronic inflammation can be deadly. St. Jude researchers have identified a molecule that might lead to new ways to shut it down.
New NMR will allow St. Jude researchers to study proteins, DNA, RNA and other biomolecules to better understand catastrophic diseases.
Powerful cancer data portal gets an upgrade to identify the genetic culprit for inherited cancer and possibly other genetic diseases.
Scientists have used a 3D genome to improve understanding of gene regulation during development and disease. Read the latest.
St. Jude researchers have uncovered the secrets of genome packaging revealed in the 3D genome.
Digital polymarese chain reaction testing can correlate the amount of virus present in a sample with clinical systems.
A fresh take on the common blood disorder, b-thalassemia leads researchers to a novel therapy using rapamycin that is ready for clinical trial.
St. Jude Children’s Research Hospital names Dr. Aseem Ansari chair of Department of Chemical Biology and Therapeutics
Aseem Ansari, Ph.D., will join St. Jude Children’s Research Hospital as chair of the Department of Chemical Biology and Therapeutics.
New study accounts for years of life lost due to cancer. It’s the first time this metric has been used to analyze the childhood cancer burden globally.
Research at St. Jude Children’s Research Hospital and Massachusetts General Hospital digs into the cells of origin for key medulloblastoma subtypes.
Explore more research news
More Research News
Clinical Trials Alerts
Our e-newsletter for clinicians offers updates on St. Jude open clinical trials and research news.
Courageous patients. Resolute doctors. Caring staff. Inventive scientists. Their voices come alive in Promise magazine.
Follow Us on Social Media
Connect with @stjuderesearch to keep up with our latest science and medical news. More about St. Jude social media.
Browse all scientific publications by St. Jude investigators.